Tyrosine phosphorylation of protein kinase CK2 by Src-related tyrosine kinases correlates with increased catalytic activity
- 15 June 2003
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 372 (3) , 841-849
- https://doi.org/10.1042/bj20021905
Abstract
Casein kinase-2 (CK2) is a pleiotropic and constitutively active serine/threonine protein kinase composed of two catalytic (α and/or α´) and two regulatory β-subunits, whose regulation is still not well understood. In the present study, we show that the catalytic subunits of human CK2, but not the regulatory β-subunits, are readily phosphorylated by the Src family protein tyrosine kinases Lyn and c-Fgr to a stoichiometry approaching 2 mol phosphotyrosine/mol CK2α with a concomitant 3-fold increase in catalytic activity. We also show that endogenous CK2α becomes tyrosine-phosphorylated in pervanadate-treated Jurkat cells. Both tyrosine phosphorylation and stimulation of activity are suppressed by the specific Src inhibitor 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine. By comparison, mutations giving rise to inactive forms of CK2α do not abrogate and, in some cases, stimulate Lyn and c-Fgr-dependent tyrosine phosphorylation of CK2. Several radiolabelled phosphopeptides could be resolved by HPLC, following tryptic digestion of CK2α that had been phosphoradiolabelled by incubation with [32P]ATP and c-Fgr. The most prominent phosphopeptide co-migrates with a synthetic peptide encompassing the 248–268 sequence, phosphorylated previously by c-Fgr at Tyr255in vitro. The identification of Tyr255 as a phosphorylated residue was also supported by MS sequencing of both the phosphorylated and non-phosphorylated 248–268 tryptic fragments from CK2α and by on-target phosphatase treatment. A CK2α mutant in which Tyr255 was replaced by phenylalanine proved less susceptible to phosphorylation and refractory to stimulation by c-Fgr.Keywords
This publication has 37 references indexed in Scilit:
- Selectivity of 4,5,6,7‐tetrabromobenzotriazole, an ATP site‐directed inhibitor of protein kinase CK2 (‘casein kinase‐2’)Published by Wiley ,2001
- A Potential Role of Nuclear Matrix-associated Protein Kinase CK2 in Protection against Drug-induced Apoptosis in Cancer CellsJournal of Biological Chemistry, 2001
- Biochemical evidence that the N‐terminal segments of the α subunit and the β subunit play interchangeable roles in the activation of protein kinase CK2FEBS Letters, 1998
- Protein Kinase CK2α′ Is Induced by Serum as a Delayed Early Gene and Cooperates with Ha-ras in Fibroblast TransformationJournal of Biological Chemistry, 1998
- Protein kinase CK2α is a target for the Abl and Bcr–Abl tyrosine kinasesOncogene, 1998
- p53 deficiency and misexpression of protein kinase CK2α collaborate in the development of thymic lymphomas in miceOncogene, 1998
- Sequence Specificity of C-Terminal Src Kinase (Csk). A Comparison with Src-Related Kinases C-Fgr and LynEuropean Journal of Biochemistry, 1997
- Halogenated Benzimidazoles and Benzotriazoles as Selective Inhibitors of Protein Kinases CK-I and CK-II from Saccharomyces Cerevisiae and Other SourcesBiochemical and Biophysical Research Communications, 1995
- Isolation and identification of two proto‐oncogene products related to c‐fgr and fyn in a tyrosine‐protein‐kinase fraction of rat spleenEuropean Journal of Biochemistry, 1993
- Spleen protein tyrosine kinases TPK‐IIB and CSK display different immunoreactivity and opposite specificities toward c‐src‐derived peptidesFEBS Letters, 1992